Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves

FEBS Letters

Volumn 579, Issue 30, 2005, Pages 6839-6845

  Ciampa, Anna R ^a   De Prati, Alessandra Carcereri ^a   Amelio, Ernesto ^b   Cavalieri, Elisabetta ^a   Persichini, Tiziana ^c   Colasanti, Marco ^c   Musci, Giovanni ^d   Marlinghaus, Ernst ^e   Suzuki, Hisanori ^a   Mariotto, Sofia ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c ROMA TRE UNIVERSITY   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e Storz Medical AG   (Switzerland)

Author keywords

Extracorporeal shock waves; Inducible nitric oxide synthase; Inflammation; NF B; Nitric oxide

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; DOWN REGULATION; ENZYME ACTIVITY; EXTRACORPOREAL LITHOTRIPSY; GENE EXPRESSION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; COMPLEX MIXTURES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOMA; HIGH-ENERGY SHOCK WAVES; INFLAMMATION; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICROSCOPY, CONFOCAL; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 28844498493     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.11.023     Document Type: Article

References (27)

1. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
2. R.W. Ganster, B.S. Taylor, L. Shao, and D.A. Geller Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappaB Proc. Natl. Acad. Sci. USA 98 2001 8638 8643
3. C. Chaussy, W. Brendel, and E. Schmiedt Extracorporeally induced destruction of kidney stone by shock waves Lancet II 1980 1265 1268
4. W. Siebert, and M. Buch Extracorporeal Shock Waves in Orthopaedics 1997 Springer-Verlag Berlin, Heidelberg, New York
5. V.D. Valchanov, and P. Michailov High energy shock waves in the treatment of delayed and nonunion of fractures Int. Orthop. 15 1991 181 184
6. D. Rompe, J. Zoellner, and B. Nafe Shock wave therapy versus conventional surgery in the treatment of calcifying tendinitis of the shoulder Clin. Orthop. 387 2001 72 82
7. M. Loew, W. Deacke, D. Kusnierczak, M. Rahmanzadeh, and V. Ewerbeck Shock-wave therapy is effective for chronic calcifying tendinitis of the shoulder J. Bone Joint Surg. 81B 1999 863 867
8. J.D. Rompe, C. Hopf, K. Kullmer, J. Heine, and R. Burger Analgesic effect of ESWT on chronic tennis elbow J. Bone Joint Surg. 78B 1996 233 237
9. D. Rompe, J. Decking, C. Schoellner, and B. Nafe Shock wave application for chronic plantar fasciitis in running athletes: a prospective, randomized, placebo-controlled trial Am. J. Sports Med. 31 2003 268 275
10. C.J. Wang, H.Y. Huang, and C.H. Pai Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs J. Foot Ankle Surg. 41 2002 16 22
11. C.J. Wang, F.S. Wang, K.D. Yang, L.H. Weng, C.C. Hsu, and C.S. Huang Shock wave therapy induces neovascularization at the tendon-bone junction. A study in the rabbits J. Orthop. Res. 21 2003 984 998
12. G. Gotte, E. Amelio, S. Russo, E. Marlinghaus, G. Musci, and H. Suzuki Short-time non-enzymatic nitric oxide synthesis from l-arginine and hydrogen peroxide induced by shock waves treatment FEBS Lett. 520 2002 153 155
13. S. Mariotto, E. Cavalieri, E. Amelio, A.R. Ciampa, A. Carcereri de Prati, and E. Marlinghaus Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production Nitric Oxide 12 2005 89 96
14. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
15. M. Colasanti, T. Persichini, E. Cavalieri, C. Fabrizi, S. Mariotto, M. Menegazzi, G.M. Lauro, and H. Suzuki Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma-induced tyrosine phosphorylation J. Biol. Chem. 274 1999 9915 9917
16. L. Osborn, S. Kunkel, and G.J. Nabel Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B Proc. Natl. Acad. Sci. USA 86 1989 2336 2340
17. M. Colasanti, T. Persichini, M. Menegazzi, S. Mariotto, E. Giordano, and C.M. Caldarera Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide J. Biol. Chem. 270 1995 26731 26733
18. G. Venturini, M. Colasanti, T. Persichini, E. Fioravanti, P. Ascenzi, and L. Palomba Beta-amyloid inhibits NOS activity by subtracting NADPH availability FASEB J. 16 2002 1970 1972
19. K. Chang, S.J. Lee, I. Cheong, T.R. Billiar, H.T. Chung, and J.A. Han Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IkappaB Exp. Mol. Med. 36 2004 311 324
20. J.I. Lee, and G.J. Burckart Nuclear factor kappa B: important transcription factor and therapeutic target J. Clin. Pharmacol. 38 1998 981 993
21. B. Zingarelli, M. Sheehan, and H.R. Wong Nuclear factor-kappaB as a therapeutic target in critical care medicine Crit. Care Med. 31 2003 S105 S111
22. H. Togashi, M. Sasaki, E. Frohman, E. Taira, R.R. Ratan, and T.M. Dawson Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression Proc. Natl. Acad. Sci. USA 94 1997 2676 2680
23. M. Colasanti, and H. Suzuki The dual personality of NO Trend Pharmacol. Sci. 21 2000 249 252
24. 2+-dependent nitric-oxide synthase activity in human astrocytoma cells J. Biol. Chem. 272 1997 7582 7585
25. L. Palomba, T. Persichini, V. Mazzone, M. Colasanti, and O. Cantoni Inhibition of nitric-oxide synthase-I (NOS-I)-dependent nitric oxide production by lipopolysaccharide plus interferon-gamma is mediated by arachidonic acid. Effects on NFkappaB activation and late inducible NOS expression J. Biol. Chem. 279 2004 29895 29901
26. S. Mariotto, M. Menegazzi, and H. Suzuki Biochemical aspects of nitric oxide Curr. Pharm. Des. 10 2004 1627 1645
27. M. Colasanti, and T. Persichini Nitric oxide: an inhibitor of NF-kappaB/rel system in glial cells Brain Res. Bull. 52 2000 155 161